Marketing-authorisation holder
Nesher Pharms
4 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
4 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| DISOPYRAMIDE PHOSPHATE150mg base · Capsule, extended release | Disopyramide | United States | Not marketed | 1987 |
| MICRO-K8MEQ **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule, extended release | Potassium chloride | United States | Not marketed | 1980 |
| MICRO-K 1010MEQ **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule, extended release | Potassium chloride | United States | Not marketed | 1980 |
| ONDANSETRON16mg | 24mg | 4mg | 8mg · Tablet, orally disintegrating | Ondansetron | United States | Marketed | 2006 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States |
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 4
- Countries
- 1
- Roles
- Authorisation holder
Work with Prognia
Keep Nesher Pharms’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a call